Evidence map›Paper›PMID 32234077›Full record

ArticleCritical care (London, England)2020

Hyperoxemia and excess oxygen use in early acute respiratory distress syndrome: insights from the LUNG SAFE study.

Fabiana Madotto, Emanuele Rezoagli, Tài Pham, Marcello Schmidt, Bairbre McNicholas, Alessandro Protti, Rakshit Panwar, Giacomo Bellani, Eddy Fan, Frank van Haren and 3 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Critical care (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02010073 (A Multicentre, Prospective, Observational, 4-week Inception Cohort Study Being Carried Out by the Acute Respiratory Failure Section of ESICM), which is not on this map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02010073 completednot on this map

A Multicentre, Prospective, Observational, 4-week Inception Cohort Study Being Carried Out by the Acute Respiratory Failure Section of ESICM

TypeobservationalSponsorEuropean Society of Intensive Care MedicineRan2014 to 2014Enrolled14,000ConditionsAcute Severe Respiratory Failure, Acute Respiratory Distress Syndrome
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Association of Arterial PaCODiagnostics (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Review
  16. Observational
  17. Article
  18. Dangers of hyperoxia.Critical care (London, England) · 2021
    Review
  19. Oxygen Toxicity in Critically Ill Adults.American journal of respiratory and critical care medicine · 2021
    Review
  20. Target arterial POAnnals of intensive care · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 4 countries.

Fabiana MadottoResearch Center on Public Health, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Emanuele RezoagliDepartment of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Tài PhamKeenan Research Centre for Biomedical Science, St Michael's Hospital, Toronto, Canada.
Marcello SchmidtInstitute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
Bairbre McNicholasNephrology, School of Medicine, National University of Ireland Galway, Galway, Ireland.
Alessandro ProttiDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele (Milan), Italy.
Rakshit PanwarIntensive Care Unit, John Hunter Hospital, New Lambton Heights, NSW, Australia.
Giacomo BellaniDepartment of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Eddy FanAnaesthesia and Intensive Care Medicine, School of Medicine, National University of Ireland Galway, Galway, Ireland.
Frank van HarenIntensive Care Unit, The Canberra Hospital and Australian National University, Canberra, Australia.
Laurent BrochardKeenan Research Centre for Biomedical Science, St Michael's Hospital, Toronto, Canada.
John G LaffeyAnaesthesia and Intensive Care Medicine, School of Medicine, National University of Ireland Galway, Galway, Ireland. john.laffey@nuigalway.ie.ORCID 0000-0002-1246-9573
LUNG SAFE Investigators and the ESICM Trials Group
St. Michael's Hospital · CAAustralian National University · AUHumanitas University · ITMultiMedica · ITJohn Hunter Hospital · AUOllscoil na Gaillimhe – University of Galway · IEUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundConcerns exist regarding the prevalence and impact of unnecessary oxygen use in patients with acute respiratory distress syndrome (ARDS). We examined this issue in patients with ARDS enrolled in the Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG SAFE) study.

methodsIn this secondary analysis of the LUNG SAFE study, we wished to determine the prevalence and the outcomes associated with hyperoxemia on day 1, sustained hyperoxemia, and excessive oxygen use in patients with early ARDS. Patients who fulfilled criteria of ARDS on day 1 and day 2 of acute hypoxemic respiratory failure were categorized based on the presence of hyperoxemia (PaO

resultsOf 2005 patients that met the inclusion criteria, 131 (6.5%) were hypoxemic (PaO

conclusionsHyperoxemia and excess oxygen use are both prevalent in early ARDS but are most often non-sustained. No relationship was found between hyperoxemia or excessive oxygen use and patient outcome in this cohort.

trial registrationLUNG-SAFE is registered with ClinicalTrials.gov, NCT02010073.

Indexed as

Hyperbaric OxygenationRespiration, ArtificialHumansIntensive Care UnitsOxygenPrevalenceRespiratory Distress SyndromeOxygenAcute respiratory distress syndromeHyperoxemiaHyperoxiaHypoxemiaHypoxiaInvasive mechanical ventilationMortalityOxygen therapy

Identifiers

PMID32234077
PMCPMC7110678
OpenAlexW3015168464

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.